If you could vote on Brexit now which option would you choose?

Arthritis drug offers hope for severely ill Covid patients

Scientists have found that a drug used to fight rheumatoid arthritis leads to significantly improved outcomes for severely ill Covid-19 patients, the latest breakthrough in the search for a potential treatment. Tocilizumab, an immunosuppressant drug, was found to be so effective in randomised controlled clinical trials involving 303 patients, that the researchers have been told to stop recruiting people to the “no treatment group”. It is the first immune-modulating drug found to have an effect on outcomes of hospitalised Covid-19 patients, adding to positive results from the cheap and plentiful steroid dexamethasone, and the antiviral drug remdesivir.

Financial Times - November 19, 2020

View the full story here: https://www.ft.com/content/4cd142d2-2922-42ac-bcd7-593a1d730a66